KUALA LUMPUR, March 19 ?CCM Duopharma Biotech Bhd will defer spending RM20 jaring of the approved capital expenditure (capex) of RM75 million for 2008-2010.
In a statement here today, it said this would be done by rescheduling the construction of a new office block and execution of phase three of the haemodialysis and irrigation capacity expansion initiative.
CCM Duopharma said it would proceed with a RM7 million upgrade and remodelling of its small volume injectables (SVI) plant and labuan malaysia it with an inert human vaccines fill and finish facility.
No comments:
Post a Comment